Literature DB >> 8219957

Cost-effectiveness analysis.

R Robinson1.   

Abstract

When different health care interventions are not expected to produce the same outcomes both the costs and the consequences of the options need to be assessed. This can be done by cost-effectiveness analysis, whereby the costs are compared with outcomes measured in natural units--for example, per life saved, per life year gained, and per pain or symptom free day. Many cost-effective analyses rely on existing published studies for effectiveness data as it is often too costly or time consuming to collect data on cost and effectiveness during a clinical trial. Where there is uncertainty about the costs and effectiveness of procedures sensitivity analysis can be used, which examines the sensitivity of the results to alternative assumptions about key variables. In this article Ray Robinson describes these methods of analysis and discusses possibilities for how the benefits of alternative interventions should be valued.

Entities:  

Mesh:

Year:  1993        PMID: 8219957      PMCID: PMC1696433          DOI: 10.1136/bmj.307.6907.793

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  13 in total

1.  Discounting and health benefits.

Authors:  M Parsonage; H Neuburger
Journal:  Health Econ       Date:  1992-04       Impact factor: 3.046

2.  Cost-effectiveness and cost-benefit analyses in the medical literature. Are the methods being used correctly?

Authors:  I S Udvarhelyi; G A Colditz; A Rai; A M Epstein
Journal:  Ann Intern Med       Date:  1992-02-01       Impact factor: 25.391

3.  Economic evaluation of neonatal intensive care of very-low-birth-weight infants.

Authors:  M H Boyle; G W Torrance; J C Sinclair; S P Horwood
Journal:  N Engl J Med       Date:  1983-06-02       Impact factor: 91.245

4.  Cost-effectiveness of duodenal ulcer treatment.

Authors:  A J Culyer; A K Maynard
Journal:  Soc Sci Med Med Econ       Date:  1981-03

5.  Cost-effectiveness of antihyperlipemic therapy in the prevention of coronary heart disease. The case of cholestyramine.

Authors:  G Oster; A M Epstein
Journal:  JAMA       Date:  1987-11-06       Impact factor: 56.272

6.  Comparing the cost-effectiveness of drug regimens in the treatment of duodenal ulcers.

Authors:  H Sintonen; V Alander
Journal:  J Health Econ       Date:  1990-06       Impact factor: 3.883

7.  An economic evaluation of transcervical endometrial resection versus abdominal hysterectomy for the treatment of menorrhagia.

Authors:  M J Sculpher; S Bryan; N Dwyer; J Hutton; G M Stirrat
Journal:  Br J Obstet Gynaecol       Date:  1993-03

8.  Cost effectiveness of clinical diagnosis, venography, and noninvasive testing in patients with symptomatic deep-vein thrombosis.

Authors:  R Hull; J Hirsh; D L Sackett; G Stoddart
Journal:  N Engl J Med       Date:  1981-06-25       Impact factor: 91.245

9.  Prevention of Lyme disease after tick bites. A cost-effectiveness analysis.

Authors:  D Magid; B Schwartz; J Craft; J S Schwartz
Journal:  N Engl J Med       Date:  1992-08-20       Impact factor: 91.245

10.  The cost-effectiveness of cervical cancer screening for low-income elderly women.

Authors:  J S Mandelblatt; M C Fahs
Journal:  JAMA       Date:  1988 Apr 22-29       Impact factor: 56.272

View more
  28 in total

Review 1.  Economic evaluation of pharmacy services--fact or fiction?

Authors:  B George; J Silcock
Journal:  Pharm World Sci       Date:  1999-08

Review 2.  Economic note: cost of illness studies.

Authors:  S Byford; D J Torgerson; J Raftery
Journal:  BMJ       Date:  2000-05-13

3.  Management of UTI in general practice: a cost effective analysis. A commentary to facilitate an understanding of economic evaluation.

Authors:  D Kernick
Journal:  Br J Gen Pract       Date:  2000-09       Impact factor: 5.386

4.  Statins and the prevention of coronary heart disease: striking a balance that is desirable, affordable, and achievable.

Authors:  L D Ritchie
Journal:  Br J Gen Pract       Date:  2000-09       Impact factor: 5.386

5.  The primary prevention of coronary heart disease with statins: practice headache or public health?

Authors:  P H Evans
Journal:  Br J Gen Pract       Date:  2000-09       Impact factor: 5.386

6.  Health economic evaluation.

Authors:  A Shiell; C Donaldson; C Mitton; G Currie
Journal:  J Epidemiol Community Health       Date:  2002-02       Impact factor: 3.710

7.  An introduction to economic evaluation.

Authors:  S Goodacre; C McCabe
Journal:  Emerg Med J       Date:  2002-05       Impact factor: 2.740

8.  Being economical with the truth: how to make your idea appear cost effective.

Authors:  S Goodacre; C McCabe
Journal:  Emerg Med J       Date:  2002-07       Impact factor: 2.740

Review 9.  Introduction to health economics for the medical practitioner.

Authors:  D P Kernick
Journal:  Postgrad Med J       Date:  2003-03       Impact factor: 2.401

Review 10.  Economic evaluations: a new avenue of outcome assessment in spinal disorders.

Authors:  Nicole van der Roer; Norbert Boos; Maurits W van Tulder
Journal:  Eur Spine J       Date:  2005-12-01       Impact factor: 3.134

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.